Internal Medicine, Rheumatology · Martinsburg, WV
NPI
1598821449
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2010 Doctor Oates Dr, Suite 104
Martinsburg, WV, 25401
Phone (304) 262-0085
Groups this clinician bills Medicare through
Medicare paid, 2024
$86K
2,218 services
Medicare patients, 2024
506
Average age 69
Drug cost, 2024
$14.4M
4,583 prescriptions
Company payments, 2025
$203
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael M Rezaian was code 99214 (office e&m - established), 730 times for 364 patients. In total Michael M Rezaian billed 2,218 services in 19 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 730 | 364 | $70.60 | $52K |
| 99213 Office E&M - Established | Office | 503 | 285 | $53.06 | $27K |
| 99211 Office E&M - Established | Office | 93 | 50 | $13.58 | $1,263 |
| J0702 Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | Office | 45 | 14 | $5.61 | $252 |
| 99203 Office E&M - New | Office | 40 | 40 | $68.06 | $2,722 |
| 99443 Telephone Services | Office | 26 | 20 | $75.54 | $1,964 |
| 20610 Joint Injection | Office | 24 | 15 | $39.06 | $937 |
By year: 2022 $129K for 1,934 services; 2023 $109K for 1,853 services; 2024 $86K for 2,218 services.
Medicare prescription drug claims, 2024
In 2024, the drug Michael M Rezaian prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 726 prescriptions and refills. In total Michael M Rezaian wrote 4,583 Medicare prescriptions that cost $14.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 726 | 1,797 | 239 | $20K |
| Prednisone Generic | 450 | 683 | 195 | $2,291 |
| Otezla Apremilast | 411 | 415 | 57 | $2.0M |
| Hydroxychloroquine Sulfate Generic | 324 | 909 | 105 | $14K |
| Rinvoq Upadacitinib | 276 | 298 | 39 | $1.9M |
| Cosentyx Sensoready (2 Pens) Secukinumab | 232 | 255 | 46 | $1.9M |
| Cosentyx Sensoready Pen Secukinumab | 222 | 223 | 43 | $1.7M |
| Enbrel Sureclick Etanercept | 184 | 191 | 25 | $1.4M |
| Methylprednisolone Generic | 115 | 131 | 71 | $900 |
| Xeljanz Xr Tofacitinib Citrate | 93 | 93 | 14 | $529K |
| Humira(Cf) Pen Adalimumab | 90 | 95 | 14 | $824K |
| Folic Acid Generic | 83 | 245 | 34 | $1,133 |
| Leflunomide Generic | 78 | 174 | 37 | $3,208 |
| Taltz Autoinjector Ixekizumab | 65 | 65 | 11 | $451K |
| Diclofenac Sodium Generic | 64 | 122 | 27 | $1,257 |
Brand drugs: 2,095 claims; generic drugs: 2,463 claims; opioid claims: 33.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael M Rezaian $203 ($203 in general payments such as food, travel and fees) from 3 companies. The largest payer was Janssen Biotech, Inc. with $99.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.